Search results for "Anticoagulation"


 
Results 51 - 60 of about 232 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Medication adherence affecting cardiovascular outcomes even in clinical trials

Two new analyses of recent cardiology trials highlighted the prevalence and potential adverse effects of nonadherence to medications.
https://immattersacp.org/weekly/archives/2022/08/16/2.htm
16 Aug 2022

Task Force finds insufficient evidence on screening for afib

The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.
https://immattersacp.org/weekly/archives/2022/02/01/3.htm
1 Feb 2022

Coding for anticoagulation as tricky as managing it

Diagnosis, lab tests and management make up the three key considerations when coding for anticoagulation management through Medicare. An expert sorts out the issues and scenarios for a variety of scenarios.
https://immattersacp.org/archives/2010/05/practice.htm
1 May 2010

Updated Beers criteria highlight medications that are risky in older patients

The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023

MKSAP Quiz: 6-month history of intermittent claudication

A 68-year-old man is evaluated for a 6-month history of intermittent claudication. His symptoms have been slowly progressive but are not life limiting. Medical history is significant for hypertension, hyperlipidemia, and carotid artery stenosis treated with left carotid endarterectomy. He is a former smoker but quit 10 years ago. Following a physical exam and lab studies, what is the most appropriate treatment to reduce this patient's cardiovascular risk?
https://immattersacp.org/weekly/archives/2022/08/23/3.htm
23 Aug 2022

Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE

Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://immattersacp.org/weekly/archives/2020/10/20/5.htm
20 Oct 2020

MKSAP Quiz: Preconception counseling for mitral stenosis

A 26-year-old woman seeks preconception counseling. She has a history of mitral stenosis and underwent mitral valve replacement with a tilting-disc mechanical prosthesis 5 years ago. Following a physical exam, lab studies, and electrocardiogram, what is the most appropriate anticoagulation regimen for this patient during the first trimester?
https://immattersacp.org/weekly/archives/2020/06/23/3.htm
23 Jun 2020

Managing DOACs in primary care

Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022

DOACs associated with lower risk of fracture than warfarin in atrial fibrillation

Patients taking apixaban, dabigatran, or rivaroxaban had lower rates of hip and vertebral fractures than those taking warfarin, with no difference seen between the direct oral anticoagulants (DOACs).
https://immattersacp.org/weekly/archives/2020/05/19/2.htm
19 May 2020

Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds

Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next